(Q47991262)

English

Enhanced protective immunity against malaria by vaccination with a recombinant adenovirus encoding the circumsporozoite protein of Plasmodium lacking the GPI-anchoring motif

scientific article published in September 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/15315836

Enhanced protective immunity against malaria by vaccination with a recombinant adenovirus encoding the circumsporozoite protein of Plasmodium lacking the GPI-anchoring motif (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/15315836

0 references

1 reference

based on heuristic

inferred from title

malaria vaccine

1 reference

based on heuristic

inferred from title

Oscar Bruna-Romero

1

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/15315836

3

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/15315836

Ricardo Gazzinelli

4

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/15315836

author name string

Carolina D Rocha

2

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/15315836

language of work or name

0 references

publication date

1 September 2004

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/15315836

number of pages

10

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/15315836

22

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/15315836

27-28

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/15315836

3575-3584

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/15315836

Migration through host cells activates Plasmodium sporozoites for infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.050

7 January 2021

Migration of Plasmodium sporozoites through cells before infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.050

7 January 2021

Gamma interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoites

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.050

7 January 2021

CD8+ cytolytic T cell clones derived against the Plasmodium yoelii circumsporozoite protein protect against malaria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.050

7 January 2021

Priming with recombinant influenza virus followed by administration of recombinant vaccinia virus induces CD8+ T-cell-mediated protective immunity against malaria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.050

7 January 2021

Complete, long-lasting protection against malaria of mice primed and boosted with two distinct viral vectors expressing the same plasmodial antigen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.050

7 January 2021

Protection of rhesus macaques against lethal Plasmodium knowlesi malaria by a heterologous DNA priming and poxvirus boosting immunization regimen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.050

7 January 2021

Persistence of protective immunity to malaria induced by DNA priming and poxvirus boosting: characterization of effector and memory CD8(+)-T-cell populations

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.050

7 January 2021

Enhanced CD8 T cell immunogenicity and protective efficacy in a mouse malaria model using a recombinant adenoviral vaccine in heterologous prime-boost immunisation regimes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.050

7 January 2021

Glycosyl-phosphatidylinositol molecules of the parasite and the host

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.050

7 January 2021

Circumsporozoite proteins of malaria parasites

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.050

7 January 2021

Requirements for glycosylphosphatidylinositol attachment are similar but not identical in mammalian cells and parasitic protozoa

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.050

7 January 2021

GPI-anchored proteins and glycoconjugates segregate into lipid rafts in Kinetoplastida

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.050

7 January 2021

The roles of the glycosylphosphatidylinositol anchor on the production and immunogenicity of recombinant ookinete surface antigen Pbs21 of Plasmodium berghei when prepared in a baculovirus expression system

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.050

7 January 2021

A glycosylphosphatidylinositol anchor signal sequence enhances the immunogenicity of a DNA vaccine encoding Plasmodium falciparum sexual-stage antigen, Pfs230.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.050

7 January 2021

Removal of the circumsporozoite protein (CSP) glycosylphosphatidylinositol signal sequence from a CSP DNA vaccine enhances induction of CSP-specific Th2 type immune responses and improvesprotection against malaria infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.050

7 January 2021

Dendritic cells can initiate protective immune responses against malaria.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.050

7 January 2021

ELISPOT assay to measure antigen-specific murine CD8(+) T cell responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.050

7 January 2021

Detection of malaria liver-stages in mice infected through the bite of a single Anopheles mosquito using a highly sensitive real-time PCR.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.050

7 January 2021

Interaction of DAP3 and FADD only after cellular disruption

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.050

7 January 2021

Cut and trim: generating MHC class I peptide ligands

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.050

7 January 2021

Multiple proteases process viral antigens for presentation by MHC class I molecules to CD8(+) T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.050

7 January 2021

Short-term antigen presentation and single clonal burst limit the magnitude of the CD8(+) T cell responses to malaria liver stages.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.050

7 January 2021

Efficient priming of CD4+ and CD8+ T cells by DNA vaccination depends on appropriate targeting of sufficient levels of immunologically relevant antigen to appropriate processing pathways

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.050

7 January 2021

Evolutionary relatedness of Plasmodium species as determined by the structure of DNA.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.050

7 January 2021

Genome sequence and comparative analysis of the model rodent malaria parasite Plasmodium yoelii yoelii

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.050

7 January 2021

Release of malaria circumsporozoite protein into the host cell cytoplasm and interaction with ribosomes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.050

7 January 2021

Malaria circumsporozoite protein inhibits protein synthesis in mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.050

7 January 2021

IL-4-secreting CD4+ T cells are crucial to the development of CD8+ T-cell responses against malaria liver stages.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.050

7 January 2021

Interferon-gamma-independent CD8+ T cell-mediated protective anti-malaria immunity elicited by recombinant adenovirus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.050

7 January 2021

A simple technique for the rescue of early region I mutations into infectious human adenovirus type 5

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.03.050

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2004.03.050

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/15315836

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/15315836

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47991262&oldid=2180892264"